EarningsQ2 2023 Earnings Report

China Resources Pharmaceutical Group Ltd. (640) Q2 2023 Earnings Report

0 Followers

DE:640 Q2 2023 EPS Results

Actual EPS€0.06

Consensus EPS―

Beat/Miss―

One Year Ago EPS€0.06

Actual Revenue€15.79B

Expected Revenue€16.80B

Beat/MissMissed by -€1.01B

YoY Revenue Growth+10.52%

QuarterQ2 2023

Date08/31/2023

TimeBefore Open

Conference CallThursday, August 31, 2023

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Aug 24, 2026	2026 (Q2)	0.05 / 0.05	0.044	6.06% (<+0.01)
Mar 25, 2026	2025 (Q4)	0.03 / 0.04	0.015	176.79% (+0.03)
Aug 26, 2025	2025 (Q2)	0.05 / 0.04	0.055	-19.51% (-0.01)
Mar 26, 2025	2024 (Q4)	0.03 / 0.01	0.022	-32.53% (>-0.01)
Oct 29, 2024	2024 (Q3)	- / -	0.059	―
Aug 29, 2024	2024 (Q2)	0.06 / 0.05	0.059	-8.07% (>-0.01)
Mar 26, 2024	2023 (Q4)	0.02 / 0.02	0.024	-7.26% (>-0.01)
Oct 30, 2023	2023 (Q3)	- / -	0.056	―
Aug 31, 2023	2023 (Q2)	- / 0.06	0.056	6.44% (<+0.01)
Mar 30, 2023	2022 (Q4)	0.02 / 0.02	0.019	4.68% (<+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed